Gerard A. Silvestri, M.D., M.S. Curriculum Vitae

SCHOOL ADDRESS Division of Pulmonary Department of Medicine College of Medicine 96 Jonathan Lucas Street Suite 812 CSB MSC 630 Charleston SC 29425

EDUCATION Year 1983 1987 1995

Institution Fairleigh Dickinson University St. Georges Unviersity, Grenada Dartmouth College

Degree B.A. M.D. M.S.

Major

POSTDOCTORAL EDUCATION Year 1990 - 1993

Institution Dartmouth Hitchcock Medical Center, Dartmouth Medical School

1988 - 1990

Hospital of St. Raphael, Yale University School of Medicine

1987 - 1988

Hospital of St. Raphael, Yale University School of Medicine

Role Fellowship in Pulmonary and Critical Care Medicine Residency, Department of Medicine Internship, Department of Medicine

FACULTY APPOINTMENTS Year 2006 - Present 2006 - Present 1998 - 2006 1993 - 1998

Institution Medical University of South Carolina, Graduate Studies Medical University of South Carolina, Medicine, Division of Pulmonary Medical University of South Carolina, Medicine, Division of Pulmonary Medical University of South Carolina, Medicine

Role Full Member Professor Associate Professor Assistant Professor

ADMINISTRATIVE POSITIONS Year 1998 - Present

Academic Title Director, Bronchoscopy Laboratory

1997 - 2000

Chairman, Interdisciplinary Team

1993 - 2004

Medical Director Respiratory Therapy

Institution Medical University of South Carolina, Medicine Medical University of South Carolina, Medicine Medical University of South Carolina, Medicine

PROFESSIONAL EXPERIENCE Year 2006 1993 - 2006 1990 - 1993

Title/Position Professor of Medicine Medical Director of Respiratory Care Instructor in Clinical Medicine

Institution/Organization Medical University of South Carolina Medical University of South Carolina

Comments

Dartmouth Medical School; Hanover, New Hampshire

PROFESSIONAL SOCIETIES/ASSOCIATIONS - INTERNATIONAL Year 2009 - 2011 2009 - 2011

Society/Association American Association of Bronchology and Interventional Pulmonology Pulmonology

Role President President

Page 1 / 10

1998

American College of Chest Physicians

Fellow

PROFESSIONAL SOCIETIES/ASSOCIATIONS - NATIONAL Year

Society/Association American College of Physicians American Thoracic Society

Role Member Member

Society/Association Chest Thorax American Review of Respiratory and Critical Care Medicine Journal of Bronchology ACP MKSAP 13

Role Peer Reviewer Peer Reviewer Peer Reviewer Editorial Board Editorial Board

BOOKS EDITED Year

2004 - Present 2003 - 2004

EDITORIAL SERVICE FOR JOURNAL Year

Society/Association Annals of Thoracic Surgery

Role Peer Reviewer

JOURNAL ARTICLES REVIEWED Year

Society/Association JAMA

Role Peer Reviewer

EDITORIAL REVIEW BOARD Year

2005 - 2007 2004 - Present 2004 - Present

Society/Association Journal of Respiratory Care New England Journal of Medicine European Respiratory Journal ACP MKSAP series Chest Physician European Respiratory review Thorax

Role Peer Reviewer Peer Reviewer Peer Reviewer Peer Reviewer Editorial Board Editorial Board Associate Editor

HONORS AND AWARDS Year 2012 2003 - Present 2003 - 2004 2002 2001 2000 1997 1996 1983 1983 1983 1982 1976

Description ACCP Ciaglia Memorial Award and Lecture for Career Contributions in Interventional Pulmonary Medicine Best Doctors in America Induction--South Carolina Faculty, AOA Medical Honor Society Nominee--Golden Apple Teaching Award, Clinical Science Faculty Recipient--the Michael E. Assey, MD Department of Internal Medicine Teaching Award Nominee--Outstanding Clinician, MUSC Hospital Nominee--Golden Apple Teaching Award, Clinical Science Faculty Nominee--Health Sciences Foundation Teacher of the Year Student Keynote Speaker, Fairleigh Dickinson University, Graduation Provost Award Fairleigh Dickinson University Outstanding Achievement and Service Graduated Magna Cum Laude, Fairleigh Dickinson University Omicron Delta Kappa, Madison Chapter Eagle Scout, Boy Scouts of America

HOSPITAL COMMITTEES Year 1998 - Present 1995 - 1996 1995

Name of Committee Managed Care Contracts Committee Health Carolina Network Contract Committee Medical Center Strategic Plan

Role Chair Member Member

Institution University Medical Associates Medical University of South Carolina Medical University Hospital Authority

EXTERNAL GOVERNANCE OR COMMITTEES Page 2 / 10

Year 2009 - Present 2006 - Present 2004 - 2006 2004 2003 - Present 2003 - Present 2002 - Present 2001 - 2004 2001 2000 - 2004 2000 - 2002 2000 - 2001 2000 2000 1999 - 2004 1999 - 2004 1999 1997 - 1999 1997 1996

Name of Committee Role Nominations committee ATS     Member Thoracic Oncology Network ACCP Chair Thoracic Oncology Network ACCP Vice-Chair Search Committee- Editor- Journal Chest Member Board of Directors Member Board of Directors Member Data Safety Monitoring Committee – Prostate, Lung, Colon, Member Ovarian (PLCO) screening trial Executive Committee University Medical Associates Treasurer Cancer Care Outcomes Research and Surveillance Consortium     Member ACCP Network Steering Committee on Interventional Chest Member Procedures     Reimbursement Committee – University Medical Associates Member Program Committee ACCP international meeting Member Program Committee Clinical Problems ATS Toronto Member Camp Bluebird - Cancer Camp Member Health Science and Policy Committee Member ACCP Thoracic Oncology Network Steering Committee, vice Vice-Chair (2004) chair 2004 Study Section NIH/NIDDK- Review health services/health Member economics grants Executive Committee - Charleston County Medical Society Member Camp Bluebird - Cancer Camp Member Member

Institution ATS Thoracic Oncology Network ACCP ACCP Chest American Association For Bronchology The Chest Foundation - ACCP National Cancer Institute University Medical Associates National Cancer Institute American College of Chest Physicians University Medical Associates ACCP ATS Camp Bluebird American College of Chest Physicians American College of Chest Physicians NIH/NIDDK Charleston County Medical Society Camp Bluebird American Cancer Society

UNIVERSITY COMMITTEES Year Name of Committee 2001 - Present Hollings Cancer Center Charity Golf Tournament 1998 - 2000 Curriculum Committee- Incorporating QI and evidenced based Medicine 1997 - 1998 Executive Committee - Center for Health Care Research 1997 Health Care Services Working Group (Ambulatory and ER care) 1996 - 1997 Utilization Task Force 1995 - 1996 Technology Assessment and Equipment committee 1995 - 1996 Resource Subcommittee of the Quality Council 1995 Marketing Task Force Information Sub-committee    

Role Chair Member

Institution Medical University of South Carolina Medical University of South Carolina

Member Member Member Member Member Member

Medical University of South Carolina Medical University of South Carolina Medical University of South Carolina Medical University of South Carolina Medical University of South Carolina Medical University of South Carolina

Name of Committee Role Clinical Council - Department of Medicine Member College of Medicine Strategic Plan for Health Services Research Member

Institution Medical University of South Carolina Medical University of South Carolina

DEPARTMENTAL COMMITTEES Year 1998 - 1999 1995 - 1997

TEACHING EXPERIENCE/CURRICULUM DEVELOPMENT Year 1996 - 2001 1993 - Present

Title/Description Co-director:  Introduction to Clinical Reasoning and Evidence Based Medicine (second year students)  Ward, Consult and ICU Attending 

RESEARCH INTERESTS

l l

Outcomes Research     Health Services Research    

INVITED PRESENTATIONS 1. ACCP lectures in Lung Cancer and Interventional Pulmonology Beijing, Shanghai, Xian, China. April 23-30, 2012. 2. Appropriate Staging of Lung Cancer, Jaipur India. January 17th, 2012.

Page 3 / 10

3. Endobronchial Ultrasound: Has it replaced Mediastinoscopy in the Diagnosis and Staging of Lung Cancer. National Thoracic Society of Greece, Athens Greece, November 22, 2011. 4. National Lung Cancer Screening Trial and implications overview. 19th Annual assembly of the American Association for Bronchology and Interventional Pulmonology.  American Association of Chest Physicians (ACCP). Honolulu, HI. October 22, 2011. 5. Results of the National Lung Cancer Screening Trial.  American Association of Chest Physicians (ACCP). Honolulu, HI. October 26, 2011. 6. Problem-based learning:  noninvasive staging of lung cancer.  American Association of Chest Physicians (ACCP). Honolulu, HI. October 26, 2011. 7. Lung cancer screening:  what do we do now?  American Association of Chest Physicians (ACCP). Kohala Coast, HI. October 28, 2011. 8. Problem-based learning: noninvasive staging of lung cancer. American Association of Chest Physicians (ACCP). November 2, 2010. 9. Faculty panel presentation: How to run a multidisciplinary Thoracic Oncology Program. American Association of Chest Physicians (ACCP). November 3,2010. 10. Lung adjuvant cisplatin evaluation: a pooled analysis by the lung adjuvant cisplatin. American Association of Chest Physicians (ACCP). November 3, 2010. 11. Literature review: thoracic surgery, cardiovascular, and lung cancer. American Association of Chest Physicians (ACCP). November 3, 2010. 12. Pro/Con Debate: The proven superiority of EBUS directed TBNA means that future fellows should be taught only EBUS-TBNA in dedicated advanced diagnostic bronchoscopy and interventional pulmonology programs. American Association of Chest Physicians (ACCP). November 4, 2010. 13. An irreverent look at screening for lung cancer. Portland, Oregon. November 2010. 14. Staging strategies for lung cancer. 15th Annual Perspectives in Thoracic Oncology Conference. New York, NY. November 2010. 15. All together now, how to run a multidisciplinary tumor board. ACCP international meeting, Vancouver Canada. Oct 22, 2010. 16. Sixty years in lung cancer. University of Michigan. October 2010. 17. Smithy Lectureship:  The future of endobronchial ultrasound and management of lung cancer. MUSC Storm Eye Institute. October 2010. 18. Difficult lung cancer case:  an international approach to care:  Controversies in screening. American Association of Chest Physicians (ACCP). October 31,  2010. 19. New changes and impact of the International Staging System.  American Association of Chest Physicians (ACCP). October 31, 2010. 20. Difficult lung cancer case:  an international approach to care:  Controversies in screening. American Association of Chest Physicians (ACCP). October 31,  2010.

MODERATOR OR PANEL PARTICIPANT 1. Interactive Session:  Thoracic Tumor Board. American Association of Chest Physicians (ACCP). Honolulu, HI. October 25, 2011.

ACCEPTED PRESENTATIONS 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19. 20. 21. 22. 23. 24. 25. 26. 27. 28. 29. 30. 31. 32. 33.

Course director for ultrasound for pulmonologists. Charleston Pulmonary Symposium: Charleston, SC, March 12, 2010. An irreverent look at screening for lung cancer. Medical Grand Rounds, Lahey Clinic. Boston, MA, March 26, 2010. An irreverent look at screening for lung cancer. Medical Grand Rounds, New York University Hospital, New York, NY, January 20, 2010. An update on the epidemiology of lung cancer: Swedish Nobel Lung Cancer Forum. Stockholm, Sweden, January 17-19, 2010. Medical Grand Rounds, Cleveland Clinic, Cleveland, Ohio, December 9, 2009. Pro/con on EBUS for lung cancer: 2009 Annual Meeting of the American Society of Chest Physicians (ACCP), San Diego, CA, October 31, 2009-November 4, 2009. EBUS for lung cancer. Medical Grand Rounds, Spartanburg Hospital System, Spartanburg, SC, November 13, 2009. A look at screening for lung cancer. Medical Grand Rounds, Charlotte Medical Center, Charlotte, NC, May 12, 2009. Chair of postgraduate course in lung cancer: American Thoracic Society (ATS) meeting, San Diego, CA, May 15, 2009. Evaluation and management of the Solitary Pulmonary Nodule. Medical Grand Rounds, St Vincent’s Hospital, New York, New York April 17,2009 Staging lung cancer, Florida 6th Annual Winter Lung Cancer Conference: Miami, Florida March 6, 2009 Year in Review: Lung Cancer. ATS 2007 Asia Pacific thoracic society guest lecturer. Brisbane Australia. December 2007 Interactive Tumor Board: Chair and Speaker Chest 2006, Salt Lake City, October 25, 2006 Controversies in Thoracic Oncology: Session Chair Chest 2006, Salt Lake City, October 25, 2006 Visiting Professor Yale University September 12-15 2006 Screening for Lung Cancer. Medical Grand Rounds, St Vincents Hospital, New York, New York September 16, 2006 Lung cancer: Management in the year 2006. American Thoracic Society International Conference. San Diego California, May 23, 2006 Visiting professor Walter Reed Army Medical Center, Bethesda Maryland, March 2006 ACCP Literature Review: Top 5 Articles in Lung Cancer Chest 2005, Montreal, November 1, 2005 Interactive Tumor Board, Chair and Speaker Chest 2005, Montreal, November 1, 2005 Screening and Staging of Lung Cancer. University of Michigan Update on Pulmonary and Critical Care October 10, 2005 Lung cancer update: University of Glascow, Glascow Scotland, April 2, 2005 Screening for Lung Cancer. Oxford University, UK, December 6, 2004 EUS/FNA for Mediastinal Staging of Lung Cancer. Chest 2004, Seattle, October 26, 2004. Abnormal CXR. What Next? Chest 2004, Seattle, October 26, 2004. Decision making and lung cancer. University College Hospitals of London, Middlesex Hospital. Grand rounds. May 11, 2005 Screening for lung cancer. District of Columbia Thoracic Society. Georgetown University, Washington, DC. April 15, 2004 Diagnosis, Staging and Treatment of Lung Cancer. American College of Physicians Annual Meeting. April 23, 2004 Update on Lung Cancer. New York State Thoracic Society Meeting. Westpoint Military Academy, New York, January 30,2004 Quality of Life of Interventional Procedures. Ancona Italy, June 20, 2003 Master Clinician in Lung Cancer. American Thoracic Society International Conference. Seattle, WA. May 18, 2003 Understanding the role of Advanced Directives in End of life care: Brussels Belgium. April 24 2003

34. Visiting Professor: Johns Hopkins University February 21, 2003 35. Thermal Tumor Destruction. ACCP Post graduate course. San Diego, Ca. November 5, 2002 Page 4 / 10

36. Tracheal Stenosis: Interventional Pulmonology Management Options. 10th Annual Scientific Assembly of the American Association for Bronchology. Chest 2003. San Diego, Ca. November 3, 2002 37. Malignant Pleural Effusions. Lung Cancer: The Guidelines and Beyond. ACCP Post graduate course. San Diego, Ca. November 2, 2002 38. Thoracic Oncology Tumor Board: The Pulmonologists Perspective. Chest 2003. San Diego, Ca. November 6, 2002 39. Metallic Stents. 9th Fellows Conference: ACCP Post graduate course. San Diego, Ca. November 2, 2002 40. Visiting Professor: Lung Cancer/Interventional Pulmonology. Hemer Germany. November 12, 2002. 41. Lung Cancer Year in Review. American Thoracic Society International Conference. Atlanta, Ga. May 20, 2002 42. Principles for Effective Screening for Lung Cancer. American Thoracic Society International Conference. Atlanta, Ga. May 20, 2002 43. Lung Cancer visiting professor. University of Pennsylvania. February 5, 2002 44. Non Invasive Staging of Lung Cancer: ACCP Post graduate course. Philadelphia, Pa. November 3, 2001 45. Lung Cancer Literature Review: ACCP Post graduate course. Philadelphia, Pa. November 3, 2001 46. Tracheal Bronchial Stenting: ACCP Post graduate course. Philadelphia, Pa. November 3, 2001 47. Palliating Endobronchial Disease: The use of electrocautery and stenting through the flexible bronchoscope. Creighton University 3rd Annual Lung Cancer Conference. Omaha Nebraska March 24, 2001 48. Lung Cancer Update: 11th Annual Charleston Pulmonary Symposium. March 26,2001 49. Post Graduate Course: Lung Cancer. ACCP Plenary Session. San Francisco, California October 22, 2000 50. Palliation for the patient with Lung Cancer. ACCP Plenary Session. San Francisco, California October 24, 2000 51. Symposium on the Diagnosis and Staging of Lung Cancer. Mini – Symposium Co- chair and Speaker. American Thoracic Society International Conference. Toronto Canada. May 7,2000 52. Lung Cancer by the Stages. The utility of Chemotherapy for Metastatic Lung Cancer. Symposium Chair and Speaker: American Thoracic Society International Conference. Toronto Canada. May 7,2000 53. Screening for lung cancer: Brazil 54. Helping Patients With Lung Cancer Make Decisions About Treatment. University of Vermont. October 8, 1999. 55. The Pulmonologists Perspective on the Diagnosis and Staging of Lung Cancer. Seventh Annual Jaffar Oncology conference. Deerborne Michigan Sept. 10, 1999 56. Update in Lung Cancer. Visiting Professor Program. Evanston Hospital Chicago Northwestern. Chicago Illinois, August 27, 1999 57. Auto-Expandable Metal Stents for Relief of Malignant Airway Obstruction. VI International Meeting on Respiratory Endoscopy, Barcelona, Spain. June 6, 1999 58. Lung Cancer: Detection, Diagnosis and Outcomes. Mini-symposium Co-chair and Speaker. American Thoracic Society International Conference. San-Diego, California April 25, 1999 59. Lung Cancer: Diagnosis and Staging. Sunrise Seminar. American Thoracic Society International Conference. San-Diego, California April 26, 1999 60. Malignant Pleural Effusion: Do Clinical Features Predict Clinical Course. American Thoracic Society International Conference. San-Diego, California April 26, 1999 61. Specialists Achieve Better Outcomes than Generalists for Lung Cancer Surgery. American Thoracic Society International Conference, Chicago Illinois April 26, 1998. 62. Palliative Care for the Dying Patient with Lung Cancer. Charleston Pulmonary Symposium. March 29,1998 63. The Pre-treatment Evaluation of Lung Cancer in the Era of Managed Care. American Association of Thoracic Surgeons. International Meeting, Washington D.C. May 4, 1997. 64. Lung Cancer in 1996: More Questions than Answers. Symposium Chair and Speaker. American Thoracic Society International Conference, San Francisco Ca. May 19, 1997. 65. 66. 67. 68. 69. 70. 71. 72.

Neo- adjuvant Therapy for Non Small Cell Lung Cancer: State of the Art or a Passing Fad. Charleston Pulmonary Symposium. March 23,1997. New Approaches to Staging Lung Cancer. Sunrise Seminar. American Thoracic Society International Conference, Seattle Washington. May 22, 1995. Intensive Care Medicine: Outcomes, Costs and Health Care Policy. Medical Grand Rounds, Medical University of South Carolina. Feb. 21, 1995. Malignant Pleural Effusion. ACCP Annual International Scientific Assembly, New Orleans, Louisiana Nov. 4, 1994 The clinical evaluation for detecting metastatic lung cancer: A meta-analysis. World Lung Cancer Conference, Colorado Springs, Colorodo June 26, 1994. Smoking Related Diseases. South Carolina Medical Association annual meeting. April 25 1994. The extrathoracic staging of bronchogenic carcinoma. VT-NH Trudeau Society, Lebanon, NH, April 3, 1992. Diagnostic significance of flow cytometric DNA analysis in Stage 1 non-small cell lung cancer. American Thoracic Society Meeting, Boston, Massachusetts, May 20, 1990.

BOOKS OR MONOGRAPHS 1. 2. 3. 4. 5. 6. 7. 8. 9. 10.

Gomez M, Silvestri GA. Pre-operative evaluation for lung cancer resection. In: Ravenel J, ed, Lung Cancer Imaging. Humana Press. In press. Gomez M, Silvestri GA. Invasive staging of non-small cell lung cancer. In: Ravenel J, ed. Lung Cancer Imaging. Humana Press. In press. Dineen KD, Silvestri GA The Epidemiology of Lung Cancer. In Scoulier Ed. Lung Cancer - In press Gomez M, Silvestri GA. Anesthesia for flexible bronchoscopy. In: Wang KP, Mehta AC, ed. Flexible Bronchoscopy. Blackwell Publishing. 2012: 53- 61. Spiro SG, Silvestri GA, Agusti A. Clinical Respiratory Medicine 4th Edition. Elsevier 2012. Philadelphia PA. Ravenel JG, Silvestri GA. Imaging of lung cancer. In Medina LS, Blackmore CC, Applegate KE, ed, Evidence-Based Imaging: Improving the Quality of Imaging in Patient Care. Revised Edition. Springer Science and Business Media, LLC.New York, NY.2011: 89-107. Alberg AJ, Silvestri GA, Simon GR. Lung Cancer: Lifestyle factors in risk, prevention, and treatment. In Encyclopedia of Lifestyle Medicine 2011. Paoletti L, Pastis N, Denlinger C, Silvestri GA. A Decade of Advances in Treatment for Early Stage Lung Cancer. In Clinics in Chest Medicine. December 2011:  Vol.32; No.4. Mehta HJ, Ross C, Silvestri GA, Decker RH.  Evaluation and treatment of high-risk patients with early-stage lung cancer. In Clinics in Chest Medicine, December 2011: Vol.32;No.4. Wang J, Silvestri GA. Training in Interventional Pulmonology. In: Beamis JF, Mathur P and Mehta AC, ed, Interventional Pulmonary Medicine, 2nd Edition. Page 5 / 10

Informa Healthcare, USA. 2010: 224-235. 11. Silvestri GA, Jett J. Bronchogenic Carcinoma. In Murray and Nadel’s Textbook of Respiratory Medicine. 5th Edition. Saunders. 2010: 1126-1144. 12. Reed CE, Silvestri GA The Diagnosis and Staging of Lung Cancer. In Shields Ed. General Thoracic Surgery. 7th Edition. Lippincott, Williams, Wilkens 2009:1375-1386 13. El-Bayoumi E, Silvestri GA. Bronchoscopy for the diagnosis and staging of lung cancer. In: Seminars In Respiratory & Critical Care Medicine 2008;29(3)261270. 14. Silvestri GA, Tanoue LT. Lung Cancer: Evolving Concepts 2008;29(3). 15. Judson MA. Vincent B. Huggins T. Silvestri GA. Sahn SA. Unusual presentations of pulmonary sarcoidosis: cases from the medical university of South Carolina. In: Seminars in Respiratory & Critical Care Medicine. 2007;28(1):75-82. 16. Ravenel JG, Silvestri GA. Imaging of Lung Cancer. In Medina LD and Blackmore CC (ed), Evidence Based Imaging. Springer; 2006. 17. Blackmore CC, Medina LD, Ravenel JG, Silvestri GA. Critically Assessing the Literature: Understanding Error and Bias. In Medina LD and Blackmore CC (ed), Evidence Based Imaging. Springer; 2006. 18. Jantz MA, Silvestri GA. Fire and Ice: Laser bronchoscopy, electrocautery and Cryotherapy. In Simoff, Sternman, Ernst Eds. Thoracic Endoscopy. Blackwell/Futura 2006: 134-154 19. Spiro SG, Silvestri GA The Treatment of Advanced Non Small Cell Lung Cancer. Current Opinion in Pulmonary Medicine 2005;11(4):287-291 20. Silvestri GA, Jett J. Bronchogenic Carcinoma. In Murray and Nadel’s Textbook of Respiratory Medicine. Saunders 2005;1357-1378 21. Reed CE, Silvestri GA The Diagnosis and Staging of Lung Cancer. In Shields Ed. General Thoracic Surgery. 6th Edition. Lippincott, Williams, Wilkens 2005 1534-1547 22. Abratt RP, Morgan GW, Silvestri GA, Willcox P. Pulmonary Complications of Radiation Therapy. Clin Chest Med 2004; 25: 167-177. 23. Pastis NJ, Silvestri GA. Tissue Procurement: Bronchoscopic Techniques In Pass Ed. Lung Cancer Principles and Practice, 3rd edition, Lippincott Williams and Wilkins, 2004, pp 358-371. 24. Jantz MA, Silvestri GA. Effects of Interventional Procedures on Quality of Life and Pulmonary Function. In: Beamis J Ed. Interventional Pulmonary Medicine, Marcel Decker 2004;609-638 25. Turrisi AT, Bogart J, Sherman C, Silvestri GA. The Role of Radiotherapy and Chemotherapy for Curative Management of Medically Inoperable and Stage III Non-Small Cell Lung Cancer, and Radiotherapy for Palliation of Symptomatic Disease. Respir Care Clin 2003;9:163-190 26. Barker JM, Silvestri GA. Lung Cancer Staging. Current Opinions in Pulmonary Medicine: 2002; 8: 287-93 27. Silverstein MD, Neitert PJ, Zoller JS, Silvestri GA. The Impact of Reductions in Tobacco Use on Life Expectancy and Population Life-Years. In: Chinitz DP, ed. The Changing Face of Health Systems. Jerusalem, Isreal: Gefen Publishing House, 2002: 61-71. 28. Lloyd C, Silvestri GA. New horizons in the mediastinal staging of non-small cell lung cancer. Ca journal Moffitt cancer center 2001; 8(4): 311-17 29. Reed CE, Silvestri GA The Diagnosis and Staging of Lung Cancer. In Shields Ed. General Thoracic Surgery. 5th Edition. 2000; (98): 1297-1310 30. Hyer JD, Silvestri GA. Diagnosis and Staging of Lung Cancer. Clin Chest Med, 2000; 21(1): 95-106. 31. Avendano C, Silvestri GA Case Based Studies in the Diagnosis and Staging of Lung Cancer. Seminars in Respiratory and Critical Care Medicine. Seminars in Respiratory and Critical Care Medicine. 2000: 21(5) 393-404 32. Murin S, Silvestri GA. Co-editors. Smoking and Related Diseases. Clinics in Chest Medicine. 2000; 21(1) 33. Silvestri GA. Lung Cancer: Evolving Strategies in Diagnosis and Treatment. Seminars in Respiratory and Critical Care Medicine 2000: 21(5). 34. Silvestri GA. Staging Strategies for Patients With Newly Diagnosed Bronchogenic Carcinoma: The Importance of the Clinical Evaluation. Seminars in Respiratory and Critical Care Medicine. 1996 ;17(4): 343-48. 35. Javed TA, Silvestri GA. Year 2005 Lung Cancer Outline. South Carolina DHEC 1996 36. Silvestri GA, Mahler DA. Dyspnea in the Elderly. Clinics in Chest Medicine. Sept. 1993; 393-404.

PEER-REVIEWED PUBLICATIONS 1. Tanner NT, Silvestri GA. Lung cancer screening with low- dose computed tomography: benefits and potential risk. Evidenced Based Medicine. In press. 2. Tammemagi MC, Hormuzd KA, Hocking MG, Church TR, Caporaso NC, Kvale PA, Chaturvedi AK, Silvestri GA, Riley TL, Commins J, Berg CD. Lung Cancer Risk for Selecting Individuals for Lung Cancer Screening. N Engl J Med. In press. 3. Silvestri GA, Gonzalez AV, Jantz M, Margolis ML, Gould MK, Tanoue LT, Harris L, Detterbeck F.  Methods for Staging Non-Small Cell Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (3rd Edition) Chest 2013: In press.    4. Wang Memoli J, Nietert PJ, Silvestri GA. Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule. Chest, 2012; 142(2):385-393. doi:10.1378/chest.11-1764. 5. Donington J, Ferguson M, Mazzone P, Handy J, Schuchert M, Fernando H, Loo B, Lanuti M, de Hoyos A, Detterbeck F,  Pennathur A, Howington J,  Landreneau R, Silvestri GA. American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High Risk Patients with Stage I Non-Small Cell Lung Cance. Chest. 2012;142(6):1620-1635 doi:10.1378/chest.12-0790    6. Silvestri GA, Feller-Kopman D, Chen A, Wahidi M, Yasafuku K, Ernst A.  An Update in Advanced Diagnostic and Therapeutic Pulmonary Procedures.  Chest.2012;142(6):1636-1644 doi:10.1378/chest.12-2326    7. Tanner NT, Sherman CA, Silvestri GA. Biomarkers in the selection of maintenance therapy in non-small cell lung cancer. Transl Lung Cancer Res 2012;1 (2):96-98. 8. Tanner NT, Pastis NJ, Silvestri GA. Training for Linear Endobronchial Ultrasound among US Pulmonary/Critical Care fellowships: A survey of fellowship directors. Chest. 2012 Aug 1. doi: 10.1378/chest.12-0212. [Epub ahead of print] 9. Paoletti L, Jardin B, Carpenter MJ, Cummings KM, Silvestri GA. Current status of tobacco policy and control. J Thorac Imaging. 2012 July;27(4):213-219. 10. Klabunde CN, Marcus PM, Han PK, Richards TB, Vernon SW, Yuan G, Silvestri GA. Lung cancer screening practices of primary care physicians: Results from a national survey. Annals of Family Medicine. 2012 Mar;10(2):102-10. 11. Tanner NT, Gomez M, Rainwater C, Neitert PJ, Simon GR, Green MR, Silvestri GA. Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thoracic Oncology. 2012.Feb;7(2):365-9. 12. Pastis NJ, Simkovich S, Silvestri GA. Understanding the economic impact of introducing a new procedure:  calculating downstream revenue of endobronchial  ultrasound (EBUS) as a model. Chest. 2012, Feb;141(2):506-12. 13. Silvestri GA, Vincent BD, Wahidi MM.  Fospropofol disodium for sedation in elderly patients undergoing flexible bronchoscopy.  Bronchol Intervent Pulmonol  2011; 18(1):15-22., NIHMSID: NIHMS294377

Page 6 / 10

14. Tanner NT, Watson P, Boylan A, Wang-Memoli J, Pastis N, Taylor K, Garrett-Mayer E, Silvestri GA. Utilizing endobronchial ultrasound with fine needle aspiration to obtain tissue for molecular analysis: a single center experience. J. Bronchology 2011;18:317-321. 15. Nietert PJ, Ravenel JG, Taylor KK, Silvestri GA. Influence of nodule detection software (NDS) on radiologists’ confidence in identifying pulmonary nodules with CT. Journal of Thoracic Imaging. In press., NIHMSID: NIHMS294364 16. Nietert PJ, Ravenel JG, Taylor KK, Silvestri GA. Influence of nodule detection software (NDS) on radiologists’ confidence in identifying pulmonary nodules with CT. J Thorac Imaging 2011;26 (1): 48-52. NIHMSID:NIHMS294364 17. Silvestri GA  Screening for Lung Cancer: It works but does it really work.  Ann Intern Med 2011;155:537-39. 18. Wang JF, El-Bayoumi E, Pastis N, Tanner N, Gomez M, Huggins J, Onicescu G, Garrett-Mayer E, Armeson K, Taylor K, Silvestri G.  Using EBUS features to  predict lymph node metastasis in patients with lung cancer. Chest. 2011.140:1550-1556. 19. Wahidi M, Prasoon J, Jantz M, Mackensen G, Barbour S, Lee P, Lamb C, Silvestri G. American College of Chest Physicians consensus statement on the use of topical anesthesia, analgesia, and sedation during flexible bronchoscopy in adult patients.  Chest. 2011.Nov;10(3):1342-50. 20. Tanner NT, Pastis NJ, Sherman C, Lewin D, Simon GS, Silvestri GA. The role of molecular  analyses in the era of personalized therapy for advanced NSCLC.  Lung Cancer. 2011 Dec 14. 21. Curran JN, Garrett-Mayer E, Carpenter MJ, Ford ME, Silvestri GA, Lackland DT, Alberg AJ.Cigarette smoking and the risk of dying from tobacco-related malignancies by race. Anticancer Res. 2011. Nov;31(11):3891-5. 22. Wang Memoli J, Nietert P, Silvestri GA.  Meta-analysis of guided bronchoscopy for the evaluation of the pulmonary nodule.  Chest. 2011. Oct 6. 23. PLCO Project Team. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening randomized controlled trial. JAMA. 2011. Jun 8;305(22):2295-303. 24. Simon GR, Silvestri GA. You just can’t call it lung cancer anymore. J Thorac Oncol. 2011 Feb;6(2):239-40. No abstract available. PMID: 21252714 [PubMed - in process] 25. Reinke LF, Shannon SE, Engelberg R, Dotolo D, Silvestri GA, and Curtis JR. Nurses’ identification of important yet under-utilized end-of-life care skills for patients with life-limiting or terminal illnesses. J Palliative Medicine 2010;13(6):753-758. 26. Watkins JM, Wahlquist AE, Zauls AJ, Fields EC, Garrett-Mayer E, Auero EG Silvestri GA, Sharma AK. High dose fractionated radiotherapy fto 80 Gy for stage I-II medically inoperable non-small-cell lung cancer. J Med Imaging Radiat Oncol 2010;54:554-561. 27. Silvestri GA.  Looking to our past to find the way forward for the American Association of Bronchology and Interventional Pulmonology.  J of Bronch & Interv  Pulm 2010;16(1):1-2. 28. Pastis NJ, Silvestri GA.  Flexible bronchoscopy without sedation:  is less of none more when it comes to sedation?  J Bronch & Interv Pulm 2010;16(1):3-4. 29. Bradford WD, Zoller J, Silvestri GA. Estimating the effect of individual time preferences on the demand for preventative health care. Southern Economic Journal.2010;76(4):1005-1031. 30. Pastis NJ Jr, Van Bakel AB, Brand TM, Ravenel JG, Gilbert GE, Silvestri GA, Judson MA. Mediastinal lymphadenopathy in patients undergoing cardiac transplant evaluation. Chest. 2010 Oct 21. [Epub ahead of print] PMID: 20966040 31. Engelberg RA, Downey L, Wenrich MD, Carline JD, Silvestri GA, Dotolo D, Nielsen EL, Curtis JR. Measuring the quality of end-of-life care. J Pain Symptom Manage. 2010 Jun;39(6):951-71.PMID: 20538181 [PubMed - indexed for MEDLINE] 32. *MUSC Hollings Cancer Prevention & Control Collaborative Publication Award, February 2010 33. Spiro SG, Tanner NT, Silvestri GA, Janes SM, Lim E, Vansteenkiste JF, Pirker R.Respirology. Lung cancer: Progress in diagnosis, staging, and therapy. 2010 Jan;15(1):44-50. PMID: 20199634 34. Wahidi MM, Silvestri GA, Coakley RD, Ferguson JS, Shepherd RW, Moses L, Conforti J, Que LG, Anstrom KJ, McGuire F, Colt H, Downie GH. A Prospective Multicenter Study of Competency Metrics and Educational Interventions in the Learning of Bronchoscopy Among New Pulmonary Fellows. Chest 2010;137 1040-1049. PMID: 19858234;PMCID 35. Bradford WD, Zoller J, Silvestri GA. Estimating the effect of individual time preferences on the use of disease screening. Southern Economic Journal 2010; 76 (4):1005-1031. PMID;PMCID 36. Jones W, Silvestri GA. The master settlement agreement and its impact on tobacco use ten years later: lessons for physicians about health policymaking. CHEST 2010. Mar;137(3):692-700.PMID:20202950 37. Tanner NT, Silvestri GA. An up to date look at lung cancer screening. CellAdh Migr 2010.Jan18;4(1). PMID:20139695 PMCID: PMC2852565 38. Tanner NT, Gomez M, Silvestri GA. Denture misadventure: an unusual case of hemoptysis nine years later. Journal of Bronchology. In press. 39. Gomez M, Tanner NT, Recavarren RA, Ravenel J, Silvestri GA. A 79-year-old female with a right paratracheal mass. Chest. 2009;135(5):1384-8. PMID:19420209 40. Wahidi MM, Silvestri GA, Coakley R, Ferguson S, Shepard RW, Moses L, Conforti J, Que L, Anstrom KJ, McGuire F, Colt H, Downie G. A prospective multi-center study of competency metrics and educational interventions in the learning of bronchoscopy among starting pulmonary fellows. Chest 2009.Oct 26. PMID:19858234 41. Stather DR, Jarand J, Silvestri GA, Tremblay A. An evaluation of procedural training in Canadian respirology fellowship programs: program directors’ and fellows’ perspectives. Can Respir J 2009; 16(2):55-59.PMID:19399309 PMCID: PMC2687562 42. Silvestri GA, Alberg AJ, Ravenel J. The Changing Epidemiology of Lung Cancer with a Focus on Screening. BMJ 2009 Aug 17;339:b3053.PMID:19687094 43. Nonemaker JM, Garrett-Mayer E, Carpenter MJ, Ford ME, Silvestri G, Lackland DT, Alberg AJ. The risk of dying from lung cancer by race: a prospective cohort study in a biracial cohort in Charleston, South Carolina. Ann Epidemiol. 2009 May;19(5):304-10. Epub 2009 Mar 9. PMID: 19269855. 44. Silvestri GA. The mounting evidence for enobronchial ultrasound. Chest 2009. Aug;136(2):327-8. PMID: 19666750 45. Nietert PJ, Ravenel JG, Leue WM, Miller JV, Taylor KK, Garrett-Mayer ES, Silvestri GA. Imprecision in automated volume measurements of pulmonary nodules and its effect on the level of uncertainty in volume doubling time estimation. Chest 2009;135(6):1580-6.PMID:19141526* 46. Gomez M, Silvestri GA. Endobronchial ultrasound for diagnosis and staging of lung cancer. Proc Am Thorac Soc 2009;6:180-186.PMID:19349486 47. Silvestri GA, Vincent BD, Wahidi MM, Robinette E, Hansbrough JR, Downie GH. A phase 3, randomized, double-blind study to assess the efficacy and safety of fospropofol disodium injection for moderate sedation in patients undergoing flexible bronchoscopy. Chest. 2009 Jan;135(1):41-7. PMID:18641105 48. Gomez, Silvestri GA. Lung cancer screening. Am J Med Sci 2008;335(1):46-50. 49. Vincent BD, El-Bayoumi E, Hoffman BJ, Doelken P, DeRosimo J, Reed CE, Silvestri GA. Real-time EBUS-guided transbronchial lymph node aspiration. Ann Thorac Surg 2008; 85:224-23. 50. Schultz EM, Sanders GD, Trotter PR, Patz EF, Silvestri, GA; Owens DK, Gould MK. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax 63 (4): 335-341; 2008. 51. Schultz EM, Silvestri GA, Gould MK. Variation in experts' beliefs about lung cancer growth, progression, and prognosis. J Thorac Oncol 2008 3(4):422-6. 52. Ravenel G, Leue WM, Nietert PJ, Miller JV, Taylor KK, Silvestri GA. Pulmonary nodule volume: effects of reconstruction parameters on automated measurement—a phantom study. Radiology 2008 May; 247 (2):400-8. 53. Ford DW. Nietert PJ. Zapka J. Zoller JS. Silvestri GA. Barriers to hospice enrollment among lung cancer patients: a survey of family members and physicians. Palliative & Supportive Care. 2008; 6(4):357-62. PMID:19006590 Page 7 / 10

54. Esnaola NF, Gebregziabher M, Knott K, Finney C, Silvestri GA, Reed CE, Ford ME. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina. Ann Thorac Surg 2008;86(1):220-6. 55. Rampey AM, Silvestri GA, Gillespie MB. Combined endoscopic and open approach to the removal of expandable metallic tracheal stents. Arch Otolaryngol Head Neck Surg. 2007; 133: 37-41. 56. Silvestri GA, Neitert PJ, Zoller J, Carter C, Bradford D. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax 2007;62:126-130. PMCID: PMC2111262 57. Vincent BD, Silvestri GA. An update on sedation and analgesia during flexible bronchcoscopy. J Bronchol 2007; 14: 173-180. 58. Vincent BD, Fraig M, Silvestri GA. A pilot study of narrow band imaging compared to white light bronchoscopy for evaluation of normal, pre-malignant and malignant airways disease. Chest 2007;131:1794-99. 59. Bach BP, Silvestri GA, Hanger M, Jett JR. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd Ed.). Chest 2007;132 (Supp):69S-77S. 60. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F. Noninvasive staging of non-small cell lung cancer: ACCP evidencedbased clinical practice guidelines (2nd Ed.). Chest 2007;132 (Supp):178S-201S. 61. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd Ed.). Chest 2007;132 (Supp):202S-220S. 62. Garwood S, Judson MA, Silvestri GA, Hoda R, Fraig M, Doelken P. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest 2007;132: 1298-1304. 63. Vignesh S, Vincent B, Silvestri GA, Hoffman BJ. Endoscopic ultrasound in the evaluation of mediastinal masses. Clin Gastro and Hep 2007;5:908-11. 64. Urbanic JJ, Turrisi AT, Sharma AK, Silvestri GA, Williams TE, Vanek KN, Sherman CA. Conformal high dose external radiation therapy, 80.5 Gy, alone for medically inoperable non-small cell lung cancer: a retrospective analysis. J Thoracic Oncol 2006; 1: 112-119. 65. Alberg AJ, Horner MJ, Daguise VG, Carpenter MJ, Mosley CM, Vincent B, Silvestri GA, Reed CE, Herbert JR. Lung and bronchus cancer disparities in South Carolina: epidemiology and strategies for prevention. J S C Med Assoc 2006;102:183-191. 66. Silvestri GA, Spiro SG. Carcinoma of the bronchus sixty years later. Thorax 2006; 61: 1023-1028. 67. Silvestri GA, Rivera MP. Targeted therapy for the treatment of advanced non–small-cell lung cancer: A review of the epidermal growth factor receptor Antagonists. Chest 2005;128:3975-84. 68. Pastis NJ, Nietert PJ, Silvestri GA. Variation in training for interventional pulmonary procedures among U.S. pulmonary/critical care fellowships: A survey of fellowship directors. Chest 2005;127:1614-21. 69. Pastis NJ, Nietert PJ, Silvestri GA. Fellows’ perspective of their training in interventional pulmonary procedures. J Bronchol 2005;12:88-95. 70. Mehta AC, Prakash UBS, Garland R, Haponik E, Moses L, Schaffner W Silvestri GA. Prevention of flexible bronchoscopy associated infection. Chest 2005 128(3):1742-55. 71. Spiro SG, Silvestri GA. One hundred years in lung cancer. Am J Resp Crit Care Med 2005;172(5):523-9. 72. Lloyd CB, Nietert PJ, Silvestri GA. Intensive care decision- making in the seriously ill and elderly. CCM 2004;32(3) 649-54. 73. Wallace MB, Ravenel J, Block MI, Fraig M, Silvestri GA, Wildi S, Schmulewitz N, Varadarajulu S Roberts S, Hoffman BJ, Hawes R, Reed CE. Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography. Ann Thorac Surg 2004;77:1763-8. 74. Schmulewitz N. Wildi SM. Varadarajulu S. Roberts S. Hawes RH. Hoffman BJ. Durkalski V. Silvestri GA. Block MI. Reed C. Wallace MB. Accuracy of EUS criteria and primary tumor site for identification of mediastinal lymph node metastasis from non-small-cell lung cancer. Gastrointestinal Endoscopy. 59 (2):205-12, 2004. 75. Wallace MB. Block M. Hoffman BJ. Hawes RH. Silvestri G. Reed CE. Mitas M. Ravenel J. Fraig M. Miller S. Jones ET. Boylan A. Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. AJRCCM 2003;167(12):1670-5. 76. Wilson MA, Judson MA, Silvestri GA, Ravenel JG. A case of primary tracheal paraganglioma. J Bronchology 2003; 10:125-128. 77. Reed CE, Harpole DH, Posther KE, Woolson S, Downey RJ, Meyers BF, Heelan RT, Macapinlac HA, Jung Sin-ho Silvestri GA, Seigal BA, Rusch VW. Results of the American College of Surgeons Oncology Group (ACOSOG) Z0050 Trial: The utility of PET in staging patients with potentially operable nonsmall cell lung cancer JTCVS 2003; 126:1943-51. 78. Silvestri GA, Tanoue LT, Margolis ML, Barker JM, Detterbeck F. The non- invasive staging of non-small cell lung cancer: The Guidelines Chest 2003; 147S156S. 79. Detterbeck F, DeCamp M, Kohman L, Silvestri GA. The invasive staging of non-small cell lung cancer: The Guidelines Chest 2003;123: 167S-175. 80. Ernst AE, Silvestri GA, Johnstone D. Interventional pulmonary procedures: guidelines from the American College of Chest Physicians. Chest 2003;123:16931717. 81. Silvestri GA, Knittig S, Nietert PJ, Zoller JS. The importance of faith on decisions regarding cancer care. J Clin Oncol 2003; 21: 1379-82. 82. Margolis ML, Christie JD, Silvestri GA, Kaiser L, Santiago S, Hansen-Flashen J. Importance of racial disparities pertaining to a single belief regarding lung cancer surgery: Results of a multi-center survey. Ann Intern Med 2003;139: 558-563. 83. Mohr LC, Rodgers KJ, Silvestri GA. Glutathione S- Transferase M1 Polymorphism and the risk of lung cancer. Anticancer Research 2003:23; 2111-2124. 84. Mitas M, Hoover L, Silvestri GA, Reed CE, Green M, Sherman C, Mikhitarian K Cole DJ, Block MI, and Gillanders WE. Lunx is a superior molecular marker for detection of non-small lung cell cancer in peripheral blood. Journal of Molecular Diagnostics 2003 5(4):237-42. PMCID:PMC1907342. 85. Handy JR, Asaph JW, Skokan L, Reed CE, Silvestri GA. Lung cancer surgery: outcomes and quality of life before and after surgery: Chest 2002; 122:21-30. 86. Avendano CE, Flume PA, Silvestri GA, King LB, Reed CE. Pulmonary complications following esophagectomy. Ann Thor Surg 2002; 922-926. 87. Silvestri GA, Sherman C, Leong SS, Flume PF, Turrisi AT. Caring for the dying patient with lung cancer. Chest 2002;122:1028-36. 88. Dineen KM, Jantz MA, Silvestri GA. Tracheobronial Stents. Journal of Bronchology: 2002; 9: 127-137. 89. Silverstein MD, Neitert PJ, Zoller JS, Silvestri GA. Predicted impact of attaining smoking reduction goals on mortality. South Med J 2001; 94(2) 176-83. 90. Wallace MB, Silvestri GA, Sahai AV, Hawes RH, Hoffman BJ, Durkalski V, Hennesey WS, Reed CE. Endoscopic ultrasound-guided fine needle aspiration for the staging of patients with carcinoma of the lung. Ann Thorac Surg 2001; 72: 1861-7. 91. Jantz M, Silvestri GA. Silicone stents versus metal stents for management of benign tracheobronchial disease: Pro metal stents. Journal of Bronchology 2000; 7 (2): 177-83. 92. Silvestri GA. Palliation for the dying patient with lung cancer. Respir Care 2000; 45 (12): 1490-96. 93. Ozgun AM, Strange C, Silvestri GA. The impact of a standardized protocol for placement of indwelling arterial catheters. Respir Care 1999; 44 (10): 1. 94. Arbakken L, Silvestri GA, Hawes R, Reed CE, Marsi V, Hoffman B. Cost-efficacy of endoscopic ultrasound with fine needle aspiration versus mediastinoscopy in patients with lung cancer and suspected mediastinal adenopathy. endoscopy 1999; 31 (9): 707-11. 95. Douzdjian V, Ferrara D, Silvestri GA. Treatment strategies for insulin-dependent diabetics with end stage renal disease: A Cost Effectiveness Decision Analysis Model AJKD 1998; 31 (5): 794-802. 96. Douzdjian V, Ferrara D, Silvestri GA. Cost-utility analysis of pancreas transplantation compared to other treatment options for type 1 diabetics with end-stage Page 8 / 10

renal disease. Transplantation 1998; 30: 278. 97. Silvestri GA, Pritchard RS, Welch HG. Preferences for chemotherapy among patients with advanced non-small cell lung cancer: a descriptive study based on scripted interviews. BMJ 1998; 317: 771-75. PMCID:PMC28665. 98. Silvestri GA, Handy J, Lackland D, Corley E, Reed CE. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 1998; 114: 675-80. 99. Jett J, Feins R, Kvale P, McLoud T, Miller Y, Perry M, Sause W, Silvestri GA, Stover D, Spiro S. ATS Statement. The pre-treatment evaluation for non-small cell lung cancer. Am J Respir Crit Care Med 1997; 156 (1): 320-332. 100. Lemense G, Reed CE, Silvestri GA. Pulmonary Blastoma: a rare lung malignancy. Lung Cancer. 1996; 15: 233-37. 101. Silvestri GA, Hoffman BJ, Bhutani MS, Hawes RH, Coppage L, Sanders-Cliette A, Reed CE. Endoscopic ultrasound with fine needle aspiration in the diagnosis and staging of lung cancer. Annals Thor Surg. 1996; 61:1441-6. 102. Silvestri GA, Littenberg B, Colice GL. The clinical evaluation for detecting metastatic lung cancer: A meta-analysis. Am J Respir Crit Care Med. 1995; 152: 225-30. 103. Colice GL, Birkmeyer JD, Black WC, Littenberg B, Silvestri GA. Cost-effectiveness of head CT in patients with lung cancer and no clinical evidence of metastases. Chest 1995;108:1264-71. 104. Hoffman BJ, Bhutani MS, Sanders- Cliette A, Reed CE, Silvestri GA, McKnight J, Van Velse A, Hawes RH. Diagnstic des adenopathies malignes au moyen de l'aspiration a l'aiguille fine echo-guidee par ultrasonographie endoscopique. Acta endoscopia 1995; 25(5): 473-4. 105. Maclennan SE, Silvestri GA, Ward J, Mahler DA. Does entrained breathing improve the economy of rowing. Med. Sci. Sports Exerc. 1994; 26(5) 610-14. 106. Silvestri GA, Colice GL. Deciding timing and technique for tracheostomies. contemporary internal medicine 1993; vol 5(3): 20-31. 107. Filderman AE, Silvestri GA, Gatsonis C, Luthringer DJ, Honig J, Flynn SD. Prognostic significance of proliferative index in Stage 1 non-small cell lung cancer. Amer Rev Resp Dis 1992; 146:707-710. 108. Silvestri GA, Lenz JE, Harper SN, Morse RA, Colice GL. The relationship of clinical findings to CT evidence of adrenal metastases in the staging of bronchogenic carcinoma. Chest 1992; 102:1748-51. 109. Nierenberg D, Disch M, Manheimer E, Patterson J, Ross J, Silvestri G, Summerhill E. Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome. Clin Pharmacol Ther 1991; 50:580-586.

ABSTRACTS (NON-PRESENTATION) 1. Wallace MB, Block MI, Gillanders W, Hoover L, Ravenel J, Durkalski V, Hoffman BJ, Hawes RH, Silvestri GA, Reed CE, Fraig M, Cole D, Mitas M. Detection of micrometastases in mediastinal lymphnodes in non small cell lung cancer patients by EUS-FNA and real- time rtPCR JTCVS. 2. Urbanic JJ, Turrisi AT, Sharma AK, Silvestri GA, Nietert PJ, Williams TE, Vanek KN, Sherman, CA, and Harley RA. Conformal high-dose external radiation therapy (CHERT) alone for medically inoperable non-small cell lung cancer (MILC) JRBP. 3. Gould MK, Mestaz PJ, Daniel J, Silvestri GA, Sanders GD. User satisfaction with computerized decision support for management of patients with pulmonary nodules. Am J Respir Crit Care Med 2012;185:A5776. 4. Gould MK, Simkovich SM, Mestaz PJ, Daniel J, Sanders GD, Silvestri GA. Predicting the probability of malignancy in patients with pulmonary nodules: comparison of clinical judgment with two validated models. Am J Respir Crit Care Med 2012;185:A4425. 5. Ravenel JG, Nietert PJ, Mehta HJ, Paoletti L, Shaftman SR, Tammemagi CM, Silvestri GA. . A Comparison Among Volumetric Nodule Measurements’ Ability to Inform Malignancy Prediction for Small Pulmonary Nodules. To be presented at the RSNA 98th Scientific Assembly and Annual Meeting, November 25-30, 2012, McCormick Place, Chicago, Illinois. 6. Paoletti L, Rifsnider O, Wheeler S, Carpenter M, Nietert P, Mayorga M, Silvestri G.  Utilizing a computer predictive model to evaluate cost-effectiveness of smoking cessation interventions and smoking related illnesses.  Chest October 2011 140:4 Meeting Abstracts 1058A; doi:10.1378/chest.1113245. 7. Paoletti L, Mehta H, Carpenter M, Nietert P, Silvestri G. How people are smoking and quitting in the United States.  Chest October 2011 140:4 Meeting Abstracts 1060A; doi:10.1378/chest.1112654. 8. Wang JS, Tanner N, Pastis N, Huggins JT, Doelken P, Silvestri GA. CT-Navigation Bronchoscopy for the Diagnosis of Peripheral Pulmonary Nodules. Accepted for presentation at the 28th annual meeting of the American Thoracic Society (ATS), New Orleans, LA, May 14-19 2010. 9. Watson PM, Tanner NT, Wang JS, Pastis NJ, Boylan AM, Silvestri GA. Markers of epithelial-mesenchymal transition as indicators of prognosis in lymph node aspirates from lung cancer patients. Accepted for presentation at the 101s t annual meeting of the American Academy of Clinical Research (AACR), 17 April 2010. 10. Tanner NT, Wang JS, Watson P, Boylan A, Silvestri GA. Identification of molecular markers that indicate prognosis in lung cancer using minimally invasive endobronchial ultrasound fine needle aspiration of lymph nodes. Accepted for presentation at the 28th annual meeting of the American Thoracic Society (ATS), New Orleans, LA, May 14-19 2010. 11. Gomez M, Ravenel J, Nietert P, Ginty F, Miller JV, Hammond C, Taylor KK, Silvestri GA. Development and testing of multivariate statistical prediction model of malignancy potential of small (